Alternative Data for Vericel
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 24 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 7,000 | Sign up | Sign up | Sign up |
| Employee Rating | 56 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 484 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 42 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,147 | Sign up | Sign up | Sign up |
| X Followers | 920 | Sign up | Sign up | Sign up |
| X Mentions | 10 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 41 | Sign up | Sign up | Sign up |
| Linkedin Employees | 499 | Sign up | Sign up | Sign up |
About Vericel
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States.
| Price | $32.84 |
| Target Price | Sign up |
| Volume | 1,541,571 |
| Market Cap | $1.68B |
| Year Range | $29.34 - $42.54 |
| Dividend Yield | 0% |
| PE Ratio | 76.56 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
Carticel Sm Service (Vericel) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035FMay 7 - GlobeNewswire |
|
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial GuidanceMay 7 - GlobeNewswire |
|
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026April 23 - GlobeNewswire |
|
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 MillionApril 2 - GlobeNewswire |
|
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBridApril 2 - GlobeNewswire |
|
Vericel awarded Health and Human Services contract valued at $196.87MApril 2 - Thefly.com |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '26 | 68M | 19M | 49M | -6.3M | -8.1M | -0.120 |
| Q4 '25 | 93M | 20M | 73M | 23M | 28M | 0.450 |
| Q3 '25 | 68M | 18M | 50M | 5.1M | 8.2M | 0.100 |
| Q2 '25 | 63M | 17M | 47M | -550,000 | 2.4M | -0.010 |
| Q1 '25 | 53M | 16M | 36M | -11M | -8.4M | -0.230 |
Insider Transactions View All
| Hopper Jonathan Mark filed to sell 75,556 shares at $35. April 6 '26 |
| Hagen Heidi filed to sell 31,850 shares at $32.4. March 25 '26 |
| Flynn Sean C. filed to sell 1,262 shares at $34.8. March 4 '26 |
| Halpin Michael filed to sell 16,080 shares at $35.3. March 4 '26 |
| Flynn Sean C. filed to sell 1,262 shares at $35.4. March 4 '26 |
Similar companies
Read more about Vericel (VCEL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Vericel
The Market Cap of Vericel is $1.68B.
As of today, Vericel's PE (Price to Earnings) ratio is 76.56.
Currently, the price of one share of Vericel stock is $32.84.
The VCEL stock price chart above provides a comprehensive visual representation of Vericel's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Vericel shares. Our platform offers an up-to-date VCEL stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Vericel (VCEL) does not offer dividends to its shareholders. Investors interested in Vericel should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Vericel are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
